SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
批准号:
2607807
负责人:
Michel C Nussenzweig
金额:
$17.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 2003-04-30
关键词:
B cell receptor B lymphocyte biological signal transduction cell differentiation chimeric proteins gene mutation gene rearrangement immunoglobulin M immunoglobulin genes laboratory mouse leukocyte activation /transformation protein structure receptor expression site directed mutagenesis tissue /cell culture
中文摘要
描述(改编自研究者摘要):B细胞抗原
受体(BCR)调节许多不同的生理重要过程
在抗体系统中。 这些生理反应可以分为两种
类别,那些是抗原独立的和那些是诱导的
抗原。 在第一个资助期内,我们确定了
mIgM和Iga-Igb信号转导之间的重要相互作用。
然后使用该信息来表明抗原独立事件
包括由膜调节几种不同的转变
免疫球蛋白(mIgm)通过Iga-Igb信号转导。 虽然
理解了与抗原的结合如何交联mIgM并激活
Iga-Igb信号转导子,mIgM通过其分子机制,
触发以诱导抗原非依赖性事件仍有待阐明。
在了解抗原非依赖性事件如何被激活方面的进展,
由于缺乏对交联剂性质的理解而受到阻碍,
所识别的BCR的结构特征,以及
新生mIgM需要在细胞表面表达,以触发这些
应答 拟议研究的长期目标是阐明
激活等位基因排斥和前B细胞的分子机制
过渡 该项目的第一部分将检查结构
B细胞发育和B细胞应答所需的伊加和IgB的特征
抗原。 该项目的第二部分将试图确定
B发育中mIgM信号传导的细胞和分子要求
细胞 项目的第三部分将试图定义
mIgM表达与等位基因排斥的关系。 这些研究
对理解B细胞如何发育和
在体内产生免疫反应。
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): B cell antigen
receptors (BCR) regulate many different physiologically important processes
in the antibody system. These physiologic responses can be divided into two
categories, those which are antigen independent and those which are induced
by antigen. During the first funding period for this grant we have defined
essential interactions between mIgM and the Iga-Igb signal transducers.
This information was then used to show that the antigen independent events
include several distinct transitions that are regulated by membrane
immunoglobulin (mIgm) through the Iga-Igb signal transducers. Although it
is understood how binding to antigen might crosslink mIgM and activate
Iga-Igb signal transducers, the molecular mechanisms by which mIgM is
triggered to induce antigen independent events remain to be elucidated.
Progress in understanding how antigen independent events are activated has
been hindered by a lack of understanding of the nature of the crosslinker,
the structural features of the BCR that are recognized, and whether the
nascent mIgM needs to be expressed on the cell surface to trigger these
responses. The long range goal of the proposed research is to elucidate the
molecular mechanisms that activate allelic exclusion and the pre-B cell
transition. The first part of the project will examine the structural
features of Iga and Igb required for B cell development and B cell responses
to antigen. The second part of the project will be to try to determine the
cellular and molecular requirements for mIgM signaling in developing B
cells. The third part of the project will aim to try to define the
relationship between mIgM expression and allelic exclusion. These studies
have potential implications for understanding how B cells develop and
produce immune responses in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10841240
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10327992
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10221136
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10221139
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10546453
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:9546037
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10331863
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10454947
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10454946
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10540735
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10300443
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:9982204
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
-
批准号:10265634
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10454949
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:9569038
-
项目类别:
-
资助金额:$136.51万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10062819
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:9982202
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10216965
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10216964
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10216967
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
海外基金